Search
Selected: I

I-FLICE, a novel inhibitor of tumor necrosis factor...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IBD-associated microbial antigens and methods of using same

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

ICAM-1 derivatives with altered ability to bind LFA-1

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Identification and characterization of novel pneumococcal...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Identification of broadly reactive DR restricted epitopes

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Identification of Hla-A2-presented T-cell epitopes derived...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Identification of new CD8 epitopes from HIV-1 proteins

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Identification of peptides that stimulate hepatitis C virus spec

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Identification of sortase gene

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

IgA1 protease fragment as carrier peptides

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Ii peptide therapeutics to enhance antigen presentation

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immune enhancing agent for treating HIV infected humans

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immune reactivity to HER-2/ neu protein for diagnosis and...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immune reactivity to HER-2/neu protein for diagnosis and treatme

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunisation against chlamydia trachomatis

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunization of dairy cattle with Mig protein

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immunizing composition and method for inducing an immune...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immuno-reactive peptide CTL epitopes of human cytomegalovirus

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immuno-reactive peptide CTL epitopes of human cytomegalovirus

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Immuno-reactive peptide CTL epitopes of human cytomegalovirus

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.